Santosh Kesari, MD, PhD, discusses a new prodrug that targets cells with a high level of PSMA expression, a protein that is present in many cancerous tumors.
Co-Chair Edward Shahady, MD, FAAFP, ABCL, interviews Kevin Peterson, MD, MPH, on what happens to Beta Cells after 3 years of GLP-1 administration, compared with insulin.
Ben Taylor, PhD, PA-C, Clinical Faculty, Georgia Regents University, speaks with fellow Co-Chair Edward Shahady, MD, FAAFP, ABCL, President and Medical Director, Diabetes Master Clinician Program Inc. about...
